Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Lung Cancer (Amsterdam, Netherlands)|August 10, 2013
Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelinesGilbert R Ferretti, Benoit Busser, Florence de Fraipont, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Expert Review of Anticancer Therapy|November 22, 2014
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?Nicolas Girard, Clarisse Audigier-Valette, Alexis B Cortot, et al.
Lung Cancer (Amsterdam, Netherlands)|January 6, 2020
Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testingAnne-Claire Toffart, Stéphane Asfari, Anne Mc Leer, et al.
Bulletin Du Cancer|July 1, 2014
[A new perspective in the treatment of non-small-cell lung cancer (NSCLC). Role of afatinib: An oral and irreversible ErbB family blocker]Marie Wislez, David Malka, Jaafar Bennouna, et al.
Frontiers in Pharmacology|March 7, 2024
Lung cancer, comorbidities, and medication: the infernal trioHélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, et al.
Respiratory Medicine and Research|July 9, 2021
Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocolSarah Sannicolo, Matteo Giaj Levra, Audrey Le Gouellec, et al.
Lung Cancer (Amsterdam, Netherlands)|December 8, 2009
Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinomaDamien Ythier, Elisabeth Brambilla, Romuald Binet, et al.
Chest|July 17, 2010
Use of intensive care in patients with nonresectable lung cancerAnne-Claire Toffart, Clémence Minet, Bruno Raynard, et al.
BMC Cancer|January 6, 2021
Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013Hubert Gheerbrant, Jean-François Timsit, Nicolas Terzi, et al.
Pageof 16